Inhibition of Mcl-1 expression by citrate enhances the effect of Bcl-xL inhibitors on human ovarian carcinoma cells

Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis

(2013) Karin Simonin et al.   APOPTOSIS

Citrate kills tumor cells through activation of apical caspases

(2012) Björn Kruspig et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Metabolic Regulation of Protein N-Alpha-Acetylation by Bcl-xL Promotes Cell Survival

(2011) Caroline H. Yi et al.   CELL

Comparative 2D-DIGE proteomic analysis of ovarian carcinoma cells: Toward a reorientation of biosynthesis pathways associated with acquired platinum resistance

(2011) Hubert Lincet et al.   Journal of Proteomics

Downregulation of Bcl-x L and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy

(2010) Emilie Varin et al.   CARCINOGENESIS

The BCL-2 Family Reunion

(2010) Jerry E. Chipuk et al.   MOLECULAR CELL

Apoptosis in cancer: Key molecular signaling pathways and therapy targets

(2009) Claudia Burz et al.   ACTA ONCOLOGICA

Bcl2 family proteins in carcinogenesis and the treatment of cancer

(2009) Anna Frenzel et al.   APOPTOSIS

Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells

(2009) K. Simonin et al.   MOLECULAR CANCER THERAPEUTICS

Bcl-2 family proteins and cancer

(2008) K W Yip et al.   ONCOGENE

Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins

(2008) K E Tagscherer et al.   ONCOGENE

The BCL-2 protein family: opposing activities that mediate cell death

(2007) Richard J. Youle et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY